STOCK TITAN
  1. Home
  2. HWELU

Healthwell Acquisition I (HWELU) Stock Price, News & Analysis

HWELU NASDAQ

Company Description

This page collects what Stock Titan holds for HWELU, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
+1.25%

Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate

acquisition
-2.78%

Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.

acquisition
-2.78%

Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I

acquisition
+0.68%

Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions

acquisition
0.00%

Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

clinical trial
0.00%

Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma

clinical trial

Healthwell Acquisition I has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial, fda approval, conferences. View all HWELU news →

SEC Filings

View All

No SEC filings available for HWELU.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months